Needle free delivery of dengue and Zika vaccines to the skin [ 2018 - 2020 ]

Research Grant

Researchers: Prof Paul Young (Principal investigator) ,  Dr Germain Fernando

Brief description There is no Zika vaccine and only one licensed dengue vaccine, which is age and region restricted because of poor efficacy. We have developed safe subunit vaccine candidates capable of inducing potent virus neutralizing antibodies and demonstrated protection from lethal dengue challenge in a mouse model. Here we are partnering with Vaxxas to undertake preclinical development and GLP toxicity trials for microarray patches delivering dengue and zika virus subunit vaccines.

Funding Amount $AUD 651,791.49

Funding Scheme Development Grants

Notes Development Grant